Novartis is one of the world's top pharmaceutical ... France, England, Italy, Russia and the US. By 1884, Bindschedler & Busch had transformed into a joint-stock company and was renamed ...

Novartis said it was updating the labelling ... The two deaths occurred in children in Russia and Kazakhstan, with the liver failure starting five to six weeks after administration of the adeno ...

While the myelofibrosis drug landscape has become more crowded since Syntara (then Pharmaxis) decided to focus on that ...

Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse ...

Swiss pharmaceutical giant Novartis will watch "very carefully" how the reciprocal tariff policy proposed by the United States unfolds in early April, Chief Executive Vas Narasimhan said on Monday.

The shopfronts are decked out in white, blue and red, with Chinese and Russian flags hanging side by side from the ceiling. Waist-high Russian dolls greet customers at the entrance. Inside ...

Describing Nasa astronaut Sunita Williams as "daughter of India", West Bengal Chief Minister Mamata Banerjee on Wednesday ...

Russia is amassing troops along its border with Ukraine for a looming attack while Kremlin dictator Vladimir Putin ignores a US-backed cease-fire proposal, Ukrainian President Volodymyr Zelensky ...

President Trump said he plans to speak to Russian President Vladimir Putin on Tuesday about ending the war in Ukraine after three years of fighting sparked by Russia's full-scale invasion of its ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A bitter and bloody war in Ukraine has devastated the country, further isolated Russia from the West and fueled economic insecurity around the world. As Russia and Ukraine prepare to discuss a ...

As of 10:08:11 AM EDT. Market Open. On Wednesday, Novartis AG (NYSE:NVS) announced safety and efficacy results from the Phase 3 program for investigational intrathecal onasemnogene abeparvovec ...